Edesa Biotech has entered an exclusive agreement with Kyorin Pharmaceutical granting Kyorin rights to develop and commercialize paridiprubart, an anti-TLR4 antibody for Acute Respiratory Distress Syndrome (ARDS), in Japan. The deal includes a $12 million upfront payment and potential milestones totaling about $134 million, plus royalties. Paridiprubart showed significant mortality reduction in Phase 3 trials, making it a promising treatment for ARDS. Kyorin will handle development and commercialization in Japan, while Edesa retains rights elsewhere, aiming to bring this innovative therapy to a major pharmaceutical market.
Edesa Biotech's agreement with Kyorin Pharmaceutical offers context for readers. For those following health-sector stocks, 100 of 150 rose and 26 fell on Pluang as of Nov 09, 2026 17:41 WIB. Notable movers include BBIO at USD 76.96 with a +3.59% change and a typical hold time of 65 days, HRTX at USD 0.29 up 2.99%, and CTXR at USD 0.54 down 2.98% with a 19-day hold time.
ITT Inc. reported a strong third quarter with revenue up 44% to over $1.40 billion and adjusted earnings rising 20% to $2.26 per share, driven by the SPX FLOW acquisition and 8% organic growth. Orders surged 58%, supported by aerospace, defense, and ...
Credit Agricole Toulouse 31 disclosed its weekly transactions involving the buyback of its cooperative investment certificates (CCI) from November 2 to November 6, 2026. The bank repurchased varying volumes daily, with prices ranging around 98.82 to ...
Heineken N.V. has repurchased a total of 9,814,488 shares under the second tranche of its €1.5 billion share buyback program, spending approximately €704 million up to November 6, 2026. This tranche is part of a larger plan announced in February 2026...
Claritev Corporation reported Q3 2026 revenues of $268.3 million, up 9.1% from the previous year, with adjusted EBITDA increasing 4.4% to $162 million. Despite a net loss of $61.8 million, the company highlighted strong growth across its solutions an...
India's quick commerce market is projected to grow from $3.65 billion in 2026 to $7.39 billion by 2032, expanding at a 12.41% CAGR. Growth is fueled by rising smartphone and internet penetration, expanding dark-store networks, and increasing demand f...
